HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

NP 252

HCID 131462
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
132031-81-3
Standard SMILES
CCCCCCCCOC(=O)C1=C(C)NC(C)=C(C(=O)NC2CC2)C1c1ccccc1[N+](=O)[O-]
InChIKey
IAWVGADTHVEXRD-UHFFFAOYSA-N
Molecular formula
C26H35N3O5
Average molar mass
469.6 g/mol
Monoisotopic mass
469.25767123

Overview

structure given in first source

Names & identifiers

Preferred name
NP 252
IUPAC
octyl 5-(cyclopropylcarbamoyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
English name
NP 252
Molecular weight
0

Names & synonyms

132031-81-3NP-252NP 2523-Pyridinecarboxylic acid, 5-((cyclopropylamino)carbonyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, octyl esterRefChem:166892octyl 5-(cyclopropylcarbamoyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylateOctyl 2,6-dimethyl-3-cyclopropylaminocarbonyl-4-o-nitrophenyl-1,4-dihydropyridine-5-carboxylatorb1699817SCHEMBL9816856DTXSID80927509AKOS0407490383-Pyridinecarboxylic acid, 1,4-dihydro-5-((cyclopropylamino)carbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-, octyl ester
Show more names
2,6-Dimethyl-3-cyclopropylaminocarbonyl-4-(o-nitrophenyl)-1,4-dihydropyridine-5-carboxylic acid octyl ester
T28191N-Cyclopropyl-2,6-dimethyl-4-(2-nitrophenyl)-5-[(octyloxy)carbonyl]-1,4-dihydropyridine-3-carboximidic acid

Database identifiers

CAS
132031-81-3

Properties

Computed structural propertiesFilling in

XLogP
5.3
Topological polar surface area
113 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
12
Heavy atoms
34
Formal charge
0
Complexity
825

Chemistry & industry

Applications · 2 items

DescriptionNP-252 is a calcium channel antagonist potentially for the treatment of angina pectoris and congestive heart failure. The vasoinhibitory effects of NP-252 were significantly stronger than those of nifedipine in canine cerebral artery. NP-252 (10(-7) and 10(-6) M) dose-dependently attenuated nifedipine-resistant Ca(++)-contraction in the presence of STA2 in both canine cerebral and coronary arteries. The inhibitory effect of combined treatment with NP-252 (10(-6) M) and nitroglycerin (10(-6) M) on nifedipine-resistant Ca(++)-contraction in the cerebral artery was additive. In aorta, only NP-252 reduced total La3+ resistant 45Ca binding. However, the increases in bound 45Ca at La3+ resistant sites and 45Ca unidirectional influx due to KCl were inhibited by both NP-252 and nifedipine.

UsesNP-252 is a calcium channel antagonist with an 20% effective dose (ED20) of 2.55 mg/kg in spontaneously hypertensive rats[1].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
PubChem CID
131462
DTXSID
DTXSID80927509
Nikkaji
J367.056B